Slingshot members are tracking this event:
Allergan's (AGN) XEN Gel Stent Approved by FDA to Reduce Intraocular Pressure (IOP) in Treatment-Resistant Glaucoma Patients
Slingshot Insights Explained
Nov 22, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Xen Gel Stent, Intraocular Pressure, Glaucoma, Treatment-resistant